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LIM kinase regulation of cytoskeletal dynamics
is required for salivary gland branching
morphogenesis
Shayoni Ray, Joseph A. Fanti*, Diego P. Macedo, and Melinda Larsen
Department of Biological Sciences, University at Albany, State University of New York, Albany, NY 12222

ABSTRACT Coordinated actin microfilament and microtubule dynamics is required for salivary gland development, although the mechanisms by which they contribute to branching
morphogenesis are not defined. Because LIM kinase (LIMK) regulates both actin and microtubule organization, we investigated the role of LIMK signaling in mouse embryonic submandibular salivary glands using ex vivo organ cultures. Both LIMK 1 and 2 were necessary for
branching morphogenesis and functioned to promote epithelial early- and late-stage cleft
progression through regulation of both microfilaments and microtubules. LIMK-dependent
regulation of these cytoskeletal systems was required to control focal adhesion protein–
dependent fibronectin assembly and integrin β1 activation, involving the LIMK effectors
cofilin and TPPP/p25, for assembly of the actin- and tubulin-based cytoskeletal systems,
respectively. We demonstrate that LIMK regulates the early stages of cleft formation—cleft
initiation, stabilization, and progression—via establishment of actin stability. Further, we
reveal a novel role for the microtubule assembly factor p25 in regulating stabilization and
elongation of late-stage progressing clefts. This study demonstrates the existence of multiple
actin- and microtubule-dependent stabilization steps that are controlled by LIMK and are
required in cleft progression during branching morphogenesis.
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INTRODUCTION
Branching morphogenesis is a developmental process used by several developing organs, including lungs, kidney, mammary glands,
and salivary glands. The submandibular salivary gland (SMG) undergoes a series of morphodynamic transformations beginning at embryonic day 11 (E11) as the oral epithelium thickens and protrudes
into the neural crest–derived mesenchyme, forming the primary
bud. Multiple clefts, or tissue indentations, appear at the basal periphery of the epithelial bud and progress into the tissue interior,
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.molbiolcell.org/cgi/doi/10.1091/mbc.E14-02-0705) on June 25, 2014.
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separating the primary bud into several smaller buds. Repeated
rounds of clefting, along with tissue growth, result in a complex
branched structure that undergoes further cellular and genetic
changes to ultimately create a functional adult gland (Patel et al.,
2006; Tucker, 2007; Knosp et al., 2012). Although many signaling
pathways have been identified that regulate branching morphogenesis, the physical changes that lead to the dynamic organ-level
shape changes are not clearly understood.
Cytoskeletal tension–mediated changes and spatial variations in
mechanical forces set up local growth differentials that play crucial
roles in tissue patterning in vivo and in vitro (Mammoto and Ingber,
2010). These mechanical cues act as intracellular signaling pathways
that are required to drive changes in cell shape, cell motility, cell
division, and cellular organization, permitting rapid transformations
in tissue shape and integrity. Although the role of cytoskeletal elements in mechanical signal transfer has been studied in much detail
in two-dimensional tissue culture systems (Parker et al., 2002;
Nelson et al., 2005), their function during tissue morphogenesis remain to be fully explored. In an early study, the role of the cytoskeleton during branching morphogenesis was first identified in the
mouse SMG (Spooner and Wessels, 1970, 1972). Electron micrographs of E13 explants treated with cytochalasin B showed reduced
2393

filamentous actin formation at both the apical and basal sides of the
epithelial cells. Cytochalasin B treatment caused loss of clefts and
inhibited morphogenesis. Of interest, when colchicine was used to
inhibit microtubule polymerization, morphogenesis was halted, but
the glands retained their three-dimensional (3D) shape. A model
was proposed in which cleft formation was attributed to the net difference in actin-dependent contractile forces between the apical
and basal cell surfaces. Microtubules were believed not to be directly required for cleft formation but were assumed to be required
for general cell division (Spooner, 1973). Later studies demonstrated
a role for ROCKI-stimulated nonmuscle myosin type II (myosin II)–
mediated cytoskeletal contractility that was responsible for fibronectin (FN) assembly and cell proliferation driving cleft progression
(Daley et al., 2009). Later it was proposed that an actin-containing
ridge that regulated cleft elongation through generation of mechanical forces acted as a dynamic matrix attachment point at the
base of the cleft (Kadoya and Yamashina, 2010). Although these
studies implicated cytoskeletal-generated tensile forces in the process of cleft formation during branching morphogenesis, little is
known regarding how the assembly/disassembly of cytoskeletal elements is coordinated during branching morphogenesis.
LIM kinases (LIMKs) control the dynamic assembly of two crucial cytoskeletal proteins, actin and microtubules (Gorovoy et al.,
2005). The LIM motif–containing protein kinase family comprises
two members, LIMK 1 and LIMK 2. The LIMK family contains two
LIM double zinc finger domains, followed by one PDZ domain and
a C-terminal catalytic domain. There is 53% overall amino acid
identity between LIMK 1 and LIMK 2 (Smolich et al., 1997), and
both isoforms function as dual-specificity protein kinases that
phosphorylate serine/threonine and tyrosine residues. LIMK 1 and
2 have been shown to be regulated by Rho GTPases in several
types of epithelial, neuronal, and tumor cells. Once activated,
LIMK phosphorylates cofilin and inactivates it, preventing cofilin
from severing filamentous actin and allowing accumulation of actin
microfilaments. LIMK-dependent cofilin phosphorylation and subsequent dysregulation of actin affect multiple cellular functions,
including actin stress fiber formation, cell migration, cell differentiation, extracellular matrix (ECM) remodeling, and metastasis
(Manetti, 2012). LIMK is also known to regulate microtubule stability. Previous reports demonstrated that LIMK colocalized with tubulin in endothelial cells, and overexpression of wild-type (WT)
LIMK1 induced microtubule destabilization, requiring the PDZ domain (Gorovoy et al., 2005). Another target of LIMK is tubulin polymerization–promoting protein, TPPP/p25 (Acevedo et al., 2007;
Heng et al., 2012). TPPP/p25 was identified as the first member of
an “intrinsically unstructured” family of unfolded proteins in oligodendrocytes in the brain, functioning as a microtubule-binding
protein (Ovádi and Orosz, 2009), but it is now understood to be
ubiquitously expressed (Acevedo et al., 2007). LIMK-mediated
phosphorylation of p25 on a serine residue inhibits its innate ability
to assemble microtubules (Acevedo et al., 2007). Thus LIMK can
act as a signaling node, coordinating several cellular- and tissuelevel responses during morphogenetic processes by regulating
both actin filament and microtubule assembly.
In this study, we investigated a novel function for LIMK-mediated
control of cytoskeletal dynamics during branching morphogenesis,
using organotypic ex vivo cultures of embryonic mouse submandibular salivary glands. The function of LIMK 1 and 2 and downstream mediators cofilin and p25 were investigated using small interfering RNA (siRNA) knockdown and a small-molecule LIMK
inhibitor in mouse SMG explants. Using live imaging and imaging of
fixed glands subjected to immunocytochemistry and confocal imag2394 | S. Ray et al.

ing, we investigated a function for LIMK signaling in the formation
of basement membrane and in the formation of clefts during SMG
branching morphogenesis.

RESULTS
LIMK 1 and 2 are involved in the control of embryonic
salivary gland cleft formation during branching
morphogenesis
Cytoskeletal dynamics is critical for SMG branching morphogenesis
(Spooner and Wessels, 1970, 1972). Because LIMK is a pivotal regulator of cytoskeletal dynamics (Manetti, 2012), we investigated the
role of LIMK during SMG branching morphogenesis. We analyzed
protein expression of LIMK 1 and 2 in developmental stages of
mouse SMG, as shown in Figure 1A. Both LIMK 1 and 2 were highly
expressed from E16 to adult stages, and moderate levels of the
proteins were found in E13–E15 (Figure 1, B and C). Because the
LIMK isoforms are differentially expressed in different cell types
(Foletta et al., 2004; Acevedo et al., 2006) and differ in subcellular
localization (Manetti, 2012), we performed immunocytochemistry to
localize them in intact E13 SMGs. LIMK 1 was diffusely localized in
both the epithelium and the mesenchyme, and LIMK 2 was predominantly located in the epithelium, as shown in Figure 1D. LIMK1
and 2 may thus both have roles in SMG development.
To determine whether LIMK isoforms affected cleft formation
during branching morphogenesis, we treated E13 SMGs with isoform-specific LIMK siRNAs. Negative control siRNA–treated glands
underwent repeated rounds of branching that yielded a highly ramified structure after 48 h, as shown in Figure 1E. Knockdown (KD) of
either LIM kinase 1 or LIMK 2 (41% KD for LIMK 1 and 51% KD for
LIMK 2; Supplemental Figure S1A) resulted in a morphology characterized by decreased branching relative to negative control glands.
Morphometric analysis demonstrated that there are fewer buds in
LIMK 1 and 2 siRNA–treated glands (Figure 1F), along with a significant reduction in the number of initiated clefts after 24 h, relative to
negative control glands (Supplemental Figure S1D). Combination of
equal amounts of LIMK1 and 2 siRNA produced no additional significant reduction in branching morphogenesis, suggesting that inhibition of either isoform is sufficient to affect cleft formation. To
determine whether LIMK signaling is active within the epithelium,
we knocked down LIMK in cultured E13 epithelial rudiments lacking
mesenchyme that were embedded in a basement membrane–derived extracellular matrix (Matrigel). As with the intact SMGs, LIMK 1
and 2 KD reduced the number of completed buds in epithelial rudiments after 24 h, as observed with bright-field microscopic images
and morphometric analysis (Figure 1, G and H). These findings thus
establish the presence and importance of LIMK 1 and 2 in epithelial
regulation of branching morphogenesis.

LIMK-mediated regulation of actin dynamics is essential
for cleft formation
To investigate LIMK-mediated regulation of actin assembly during
branching morphogenesis, we used a small-molecule inhibitor of
LIMK that specifically modulates its actin-dependent downstream
effects, independent of the microtubule-mediated effects. BMS-5 is
a phenyl-pyrazolyl-thiazolyl-amide–substituted molecule that is
known to be a highly selective and potent inhibitor of both LIMK 1
and 2 (Scott et al., 2010; He et al., 2012). When we treated E13
SMGs with 15 μM BMS-5 for 48 h, the treated glands underwent
significantly fewer rounds of branching and displayed elongated
buds relative to vehicle-treated glands, as demonstrated in Figure
2A. Morphometric analysis revealed a significant reduction in the
number of completed buds, as seen in Figure 2B, and also in the
Molecular Biology of the Cell

the activation state of cofilin in the presence
and absence of LIMK, using an antibody to
detect cofilin that has been phosphorylated
at Ser-3 and inactivated. Phosphorylated cofilin is localized intensely at the basal periphery of the epithelium and at the side walls of
the cleft (Figure 2F), as detected with immunocytochemistry and confocal imaging.
BMS-5 and both LIMK siRNAs stimulated a
significant decrease in levels of phosphorylated cofilin, as examined through immunochemistry and Western blots (Figure 2, C, E,
and F, and Supplemental Figure S2A). Because LIMK is known to affect actin stability
through cofilin, we next questioned how cofilin KD affects cleft formation. Cofilin was
found to be expressed abundantly throughout the E13 to adult stages, as shown in
Figure 2G. When E13 SMGs were treated
with cofilin siRNA (40% KD; Supplemental
Figure S1B), a considerable loss in branched
epithelial architecture was observed. A significant reduction in the number of completed buds was seen, as well as a reduction
in stable initiated clefts, as calculated
through morphometric analysis (Figure 2H
and Supplemental Figure S1D, respectively).
Cofilin knockdown induced an increase in Factin, as detected with rhodamine–phalloidin in the explants (Figure 2I). These results
demonstrate that alteration in actin stability,
by either increasing (cofilin KD) or decreasing (LIMK inhibition by BMS-5) the proportion of filamentous actin in the salivary epithelium, causes a significant perturbation in
branching morphogenesis.
A consequence of altered actin assembly
is changes in cell shape. LIMK has been
found to affect tumor cell morphology in 3D
matrices (Mishima et al., 2010). We therefore questioned whether LIMK inhibition
had any significant effect on cell shape durFIGURE 1: LIMK 1 and 2 are required during early development of salivary glands. (A) Western
ing organogenesis. The embryonic epitheblot analysis and densitometric quantification of total SMG protein extracts shows LIMK 1 and 2
lial bud at E13 is organized into outer cuboiisoforms to be present in the embryonic stages E13–E18, postnatal day 5 (P5), and adult.
dal cells (OCCs) near the basal periphery
(B, C) LIMK 1 and 2 protein expression levels quantified relative to GAPDH levels, respectively.
(D) E13 SMG organ explants were grown for 24 h and subjected to ICC/confocal imaging. LIMK
and inner polymorphic cells (IPCs) in the in1 (red, top) is in both epithelium and mesenchyme, outside the basement membrane, as
terior of the bud (Daley et al., 2012). Under
indicated by collagen IV (blue). LIMK 2 (red, bottom) is found primarily in the epithelium. Scale,
LIMK inhibition with BMS-5, the organiza50 μm (left, 20×), 20 μm (right, 63×). (E) E13 SMGs were treated with LIMK1, 2, or 1 + 2 siRNA
tional distinction between OCCs and IPCs
and subjected to bright-field imaging. Scale, 200 μm. (F) Morphometric analysis shows a
was lost (Supplemental Figure S2B) with a
significant reduction in bud number (fold change 48 h/2 h) with LIMK 1, 2, or 1 + 2 siRNA relative
decrease in both the cell perimeter (Suppleto negative control (n = 15). (G) Mesenchyme-free E13 epithelial rudiments treated with LIMK 1,
2, or 1 + 2 siRNA also show a decrease in branching after 48 h. Scale, 200 μm. (H) Morphometric mental Figure S2C) and area (Supplemental
Figure S2D). To confirm that BMS-5 was not
analysis of fold changes in bud number reveals a reduction in completed buds in LIMK 1, 2, or 1
toxic, we performed inhibitor washout ex+ 2 siRNA–treated glands at 48 h (n = 10). *p < 0.05, **p < 0.01, ***p < 0.001, ANOVA.
periments after 24 h of BMS-5 treatment.
number of stable initiated clefts after 24 h, relative to negative
E13 SMGs showed significant structural recovery through increased
control glands (Supplemental Figure S1D). Because LIMK is known
branching (Supplemental Figure S3A), formation of acinar units with
to inhibit the actin-severing activity of cofilin (Yang et al., 1998;
cortical localization of F-actin (Supplemental Figure S3D), and inSumi et al., 1999), we examined the levels of G- and F-actin. Immunocreased levels of phospho-cofilin (Ser-3; Supplemental Figure S3, B
cytochemistry and confocal imaging revealed an increase in G-actin
and C) after 48 h of washout. BMS-5 did not induce cell death, as
and a concomitant loss of cortical F-actin distribution in the epitheobserved by cleaved caspase-3 staining (Supplemental Figure S2F).
lium of the BMS-5–treated explants (Figure 2D). We also examined
Taken together, these results demonstrate that LIMK is able to
Volume 25 August 15, 2014
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significantly alter cell shape through reorganization of actin filaments during branching
morphogenesis in the mouse salivary
gland.

Regulation of microtubule dynamics by
TPPP/p25 and LIMK is required during
branching morphogenesis

FIGURE 2: Actin dynamics regulated by LIMK and cofilin is required for cleft formation. (A) E13
SMG organ explants were grown for 48 h ± a pharmacological inhibitor of LIMK, BMS-5. Scale,
200 μm. (B) Morphometric analysis shows a significant reduction in the fold change in buds in
the presence of BMS-5 after 48 h of incubation; n = 15, paired t test. (C) Quantification of
Western blots of E13 SMGs extracts treated with BMS-5 for 48 h confirm LIMK-mediated
inhibition of cofilin phosphorylation at Ser-3; n = 4, paired t test. (D) Confocal images of ICC for
G-actin (green) and F-actin (red) after 48 h of BMS-5 treatment in E13 SMGs. Quantification of
multiple images shows increased G- and reduced F-actin in the epithelium of BMS-5–treated
glands. Scale, 20 μm; n = 5, paired t test. (E) Quantification of Western blots of E13 SMG treated
with LIMK 1 or 2 siRNA and examined for cofilin phosphorylation at Ser-3 shows reduced levels
of phosphorylated cofilin with LIMK KD; n = 4, ANOVA. (F) Immunocytochemistry and confocal
imaging detects phospho-ser3-cofilin localized in the cleft region of untreated E13 glands and
decreased phospho-ser3-cofilin in LIMK 1 and 2 siRNA–treated E13 glands after 48 h.
Quantification of images from multiple SMGs indicates overall reduction of phospho-cofilin
levels with LIMK KD. Scale, 20 μm; n = 5, ANOVA. (G) Western blot and densitometric
quantification show cofilin to be present in the developmental stages E13–E18, P5, and adult.
(H) E13 SMG organ explants were grown for 24 h ± cofilin siRNA. Morphometric analysis shows
2396 | S. Ray et al.

Because LIMK also regulates microtubule
stability, we hypothesized that LIMK could
contribute to morphogenesis through regulation of microtubule organization. LIMK 1
phosphorylates p25 on a serine residue in
vitro, and this inactivation of p25 leads to
microtubule disassembly in vitro and in
NIH3T3 cells (Acevedo et al., 2007). LIMK 2
also interacts with p25 during astral microtubule organization in HeLa cells (Heng et al.,
2012). We examined p25 protein levels in
mouse salivary glands at multiple developmental time points and found that it is present at moderate amounts in E13–E15 (Figure
3A). Knocking down p25 with a specific
siRNA (54% knockdown at the protein level;
Supplemental Figure S1C) led to a significant reduction in branching morphogenesis
(Figure 3B), and morphometric analysis revealed a substantial lack of completed buds
(Figure 3C). Because p25 is known to control the distribution and localization of βtubulin, we examined its effect on microtubules using ICC and confocal imaging in
p25 siRNA–treated E13 SMGs. p25 KD induced a diffuse distribution of β-tubulin in
the epithelium that obscured the distinct
cell borders apparent in the negative control–treated glands (Figure 3D). In comparison, glands treated with LIMK 1 and 2 KD
exhibited thick filamentous microtubules
around the periphery of the cells throughout
the epithelium as compared with negative
control siRNA–treated glands (Figure 3E).
When SMGs were treated with Taxol, a similar increase in β-tubulin staining intensity, as
seen with LIMK 1 and 2 KD, was observed as
a result of overstabilization of microtubules
(Supplemental Figure S2E). These data
demonstrate that LIMK-mediated microtubule stability is essential during branching
morphogenesis and suggest that this function may be mediated through p25. Formation of new buds thus requires a fine organizational balance of microtubules and

a reduction in completed buds after 24 h.
Scale, 200 μm; n = 6, paired t test.
(I) Confocal images of ICC for F-actin (red) of
E13 SMGs treated for 24 h ± cofilin siRNA.
Quantification of images from multiple SMGs
shows increased F-actin with cofilin KD.
Scale, 200 μm; n = 4, paired t test. **p < 0.01,
***p < 0.001.
Molecular Biology of the Cell

aberrant disassembly (via p25 KD) or assembly (via LIMK KD) of microtubule network is
detrimental to branching morphogenesis in
the mouse salivary gland.

LIMK inhibition exerts multistep
control on cleft formation via
disruption of actin and microtubule
dynamics

FIGURE 3: Regulation of microtubule dynamics by TPPP/p25 and LIMK is required during
branching morphogenesis. (A) Western blot analysis and densitometric quantification show
developmental expression of p25 protein from E13 to E18, P5, and adult. (B) E13 SMG organ
explants were grown for 24 h ± p25 siRNA and imaged with bright-field microscopy. Scale,
200 μm. (C) Morphometric analysis shows a significant reduction in buds with p25 KD; n =
10, paired t test, **p < 0.01. (D) Mesenchyme-free E13 SMG rudiments were grown for 24 h
± p25 siRNA, stained for SyBr green (green), and subjected to ICC for β-tubulin (cyan) and
imaged with confocal microscopy. In p25 KD, β-tubulin exhibits a diffuse distribution in the
epithelium relative to negative control siRNA–treated glands (as seen in zoomed-in image),
indicative of reduced microtubule stability. Scale, 20 μm. (E) Mesenchyme-free E13 SMG
rudiments were grown for 48 h ± LIMK 1 or 2 siRNA vs. negative control siRNA. LIMK 1 and
2 KD demonstrated increased β-tubulin staining at the cell borders (bottom, zoomed-in area)
in the epithelium relative to negative control siRNA–treated glands, indicative of
overstabilized microtubules. Scale, 20 μm.
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To specifically examine the role of cytoskeletal stability on cleft progression, we performed time-lapse microscopy on BMS-5–,
LIMK siRNA–, cofilin siRNA–, and p25
siRNA–treated glands. In vehicle control–
treated epithelium (dimethyl sulfoxide
[DMSO]), initiated clefts continue to progress over time and terminate with a widened base, as exemplified in Figure 4A
(progressing cleft; green arrow). In contrast, in BMS-5–treated epithelium, initiated clefts that were <40–45 μm in length
were gradually lost during 20 h of incubation (early stage, regressing cleft; blue arrow). This cleft regression is consistent with
the previous observation that cytochalasin
B causes loss of clefts, although the length
of the lost clefts was not reported (Spooner
and Wessels, 1972). In this study, clefts that
were >45 μm in length persisted but progressed very slowly compared with clefts
in vehicle-treated controls (late stage or
delayed cleft; red arrow). When cleft progression was plotted against time, the rate
of cleft growth in vehicle-treated glands
was 6.8 μm/h, but for BMS-5–treated
glands (late stage or delayed cleft), it was
only 3.1 μm/h. Time-lapse microscopy with
cofilin KD also showed that short progressive clefts elongate very slowly and display
lack of termination under 20 h of incubation with siRNA, as seen in Supplemental
Figure S1E. Time-lapse microscopy with
p25 KD revealed that progression-competent clefts as long as 65 μm regressed in
24 h. Only those clefts that were near termination and starting to widen at the base
were retained, as shown in Figure 4B. With
LIMK 1/2 siRNA, which regulates both actin and microtubule stability, not only
smaller clefts, but also clefts as long as
65–70 μm, were found to regress in 24 h.
However, longer clefts that had widened,
yielding subdivision of the epithelial bud,
were retained, as shown in Figure 4C.
Taken together, these data establish a requirement for actin in the early stages of
cleft stabilization and progression, whereas
dynamic regulation of microtubules appears to be required mainly at the later
stages of cleft formation.

LIMK, cytoskeleton in cleft formation
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microtubules, as detected with β-tubulin
immunocytochemistry (Figure 5B), and also
did not affect cell proliferation, as detected
with 5-ethynyl-2′-deoxyuridine (EdU)–positive cells in S phase (Figure 5C). With
p25 KD, which caused microtubules to disassemble in E13 SMGs, it was observed
that there was no overall growth in the tissues. Western blot analysis detected a significant decrease in cell proliferation with
reduced pHH3 levels in glands treated with
p25 siRNA (Figure 5D). These data are consistent with the hypothesis that proper control of microtubule organization by LIMK
and p25 is required for regulation of proliferation in the developing SMG.

LIMK regulates cleft stabilization
through focal adhesion activation
and hence FN assembly in an integrindependent manner
Focal adhesions (FAs) are multimeric protein complexes that function as mechanosensors through integrins to mediate bidirectional interactions between the
cytoskeleton and ECM proteins (Wozniak
et al., 2004). Of interest, LIMK1 was previously found to affect focal adhesion activation in fibroblasts and breast cancer cells
(Foletta et al., 2004; McConnell et al., 2011),
and overexpressing WT LIMK 1 and 2
caused an increase in the size and number
of focal adhesion complexes (Sumi et al.,
1999). Because both LIMK siRNA- and BMS5–treated glands showed regression of progressive clefts along with a lack of stable
initiated clefts 24 h after culture, we hypothesized that LIMK-mediated stimulation of
FIGURE 4: LIMK knockdown and inhibition result in lack of cleft stabilization and inhibition of
cleft progression. (A) E13 SMGs were treated ± BMS-5 and subjected to bright-field time-lapse
focal adhesion assembly is responsible for
imaging. Images captured at times indicated a complete cycle of cleft initiation, progression,
regulating cleft stability during cleft proand termination (green arrowhead) in vehicle-treated (DMSO) SMGs. With BMS-5 treatment,
gression. In E13 epithelial rudiments, phosearly-stage clefts regress (blue arrowhead) and later-stage clefts show slower progression (red
phorylated FAK and the adaptor proteins
arrowhead). Distance vs. time plot for clefts in vehicle control– and BMS-5–treated glands show
localized primarily at the basal periphery of
different patterns for cleft progression for multiple clefts (n = 12). Scale, 50 μm. (B) E13 SMGs
the epithelium and along the sides of the
treated with p25 siRNA and subjected to bright-field time-lapse imaging demonstrate that p25
cleft walls under control conditions (Figure
KD causes regression of late-stage progressive clefts (blue arrowheads). Scale, 100 μm. (C) E13
6, A and B). When E13 epithelial rudiments
SMGs were treated with LIMK 1 or 2 siRNAs and subjected to bright-field time-lapse imaging.
were treated with BMS-5, LIMK 1, LIMK 2,
LIMK 1 and 2 KD reveals regression of both early-stage (blue arrowheads) and late-stage (red
or p25 siRNA, we found a decrease in levels
arrowheads) clefts after 24 h of incubation. Scale, 200 μm.
of phosphorylated FAK at both the autophosphorylated and Src-phosphorylated tyrosines (Y397 and
LIMK regulation of cell proliferation is required for
Y576/577, respectively) in the cleft region, along with a lack of rebranching morphogenesis
cruitment of the adaptor proteins talin and vinculin, relative to negBecause cell proliferation is a major contributor to branching morative control siRNA–treated glands. Cofilin KD was also found to
phogenesis, we investigated the change in cell proliferation in
reduce the levels of phosphorylated FAK (Y397 and Y576/577), vinLIMK-inhibited glands. Although cell proliferation is required for
culin, and talin in the cleft regions (Supplemental Figure S3, E and
branching, clefts can still form when proliferation is inhibited
F). Western analysis in intact E13 SMGs treated with LIMK siRNA
(Nakanishi et al., 1987). Cleft progression does require cell prolifshowed a 44% reduction, and SMGs treated with p25 siRNA showed
eration, which is, in part, stimulated by FN (Daley et al., 2009).
a 47% reduction in phosphorylated FAK (Y397; Figure 6C). With
When LIMK-inhibited E13 glands were examined for proliferation,
BMS-5 treatment, a 46% reduction in phosphorylated FAK (Y397)
it was apparent that LIMK KD significantly reduced phosphorylaand a 67% decrease in phosphorylated FAK (Y576/77) relative to
tion of histone H3 (pHH3), an M-phase marker, relative to negative
DMSO-treated glands was observed (Figure 6D), consistent with
control SMGs (Figure 5A). As reported previously (Ross-Macdonald
the ICC data. A minor reduction in phosphopaxillin at Tyr-118 was
et al., 2008), BMS-5 did not affect the organization or stability of
2398 | S. Ray et al.
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Because integrin β1 is required for
branching morphogenesis (Sakai et al.,
2003), we assayed for β1-integrin activation
in the LIMK-inhibited SMG explants. Mesenchyme-free E13 epithelial rudiments were
treated with the LIMK inhibitor BMS-5 and
LIMK and p25 siRNAs. Integrin activation
was assayed using the 9EG7 monoclonal
antibody to detect active integrin β1 relative
to total integrin β1. 9EG7 was found to stain
most intensely at the basal periphery of the
epithelial buds (Figure 7A), whereas β1 integrin antibody stained diffusely in the entire
epithelium. With LIMK inhibition and knockdown, although there was no change in total integrin β1 staining intensity, there was a
significant decrease in integrin β1 activation
compared with control SMGs. As shown in
Figure 7A, 9EG7 staining decreased in the
basolaterally located epithelial cells in BMS5–treated SMGS and also in LIMK 1, LIMK 2,
and p25 siRNA–treated SMGs. These data
suggest that the reduced activation of integrin β1 with inhibition of LIMK can be attributed to the perturbation of the dynamic
turnover of microtubules and actin.
FN has been long known to regulate
cleft progression, during which epithelial
cell–cell adhesions are continuously replaced by cell–matrix adhesions as FN is assembled in the progressing clefts (Sakai
et al., 2003; Larsen et al., 2006; Onodera
et al., 2010). Because BMS-5–treated clefts
displayed significantly reduced rates of progression, we hypothesized that LIMK regulation of FN matrix assembly is required for
efficient cleft progression. LIMK 1 was previously shown to promote FN-mediated cell
attachment through focal adhesion formation in two-dimensional cell culture (Horita
et al., 2008). Under conditions of LIMK inhibition, LIMK KD, cofilin KD, and p25 KD,
intact organ explants were immunostained
with an anti-FN antibody, which showed
FIGURE 5: LIMK regulates epithelial proliferation during branching morphogenesis. (A) E13
disorganized and uneven FN staining in the
SMGs were treated with LIMK 1 or 2 siRNA for 48 h and subjected to Western analysis.
basement membrane region (Figure 7C).
Densitometric quantification reveals that LIMK 1 and 2 KD reduces proliferation, as detected by
We used mesenchyme-free epithelial rudiphospho–histone 3 (pHH3), relative to negative control siRNA–treated glands; n = 3, **p < 0.01,
ANOVA. (B) E13 SMGs were treated with BMS-5 for 48 h and subjected to ICC/confocal imaging
ments and pretreated them with a low
to detect β-tubulin. Scale, 20 μm. Quantification reveals that BMS-5 did not alter staining intensity amount of Alexa 647–labeled purified
or epithelial localization of β-tubulin relative to DMSO-treated glands; n = 4, paired t test.
human plasma FN sufficient to label the
(C) Quantification of fluorescence intensity reveals that BMS-5 did not alter the proliferative
basement membrane without significantly
capacity of epithelial cells relative to vehicle control–treated glands, as detected with EdU
affecting branching morphogenesis. When
staining (red) relative to total nuclei (SyBr Green, pseudo colored blue). Scale, 20 μm; n = 3,
E13 epithelial rudiments pretreated with
paired t test. (D) Western blot and densitometric analysis shows p25 siRNA reduces pHH3 in
labeled plasma FN were incubated with
comparison to negative control siRNA–treated glands after 24 h; n = 4, **p < 0.01, paired t test.
BMS-5, LIMK 1 + 2 siRNA, or p25 siRNA,
significant differences in FN matrix organiobserved in LIMK and p25 KD glands (Supplemental Figure S2I),
zation were observed in comparison with control SMGs. In negative
with almost no reduction in the presence of BMS-5 (Supplemental
control siRNA–treated SMGs, substantial deposition of FN matrix,
Figure S2, G and H). Together these data indicate that LIMK-medias labeled by Alexa 647–FN (Figure 7B), was detected. In contrast,
ated assembly of focal adhesion protein–containing complexes designificantly decreased FN deposition in the basement membrane
pend on dynamic assembly/disassembly of both actin filaments
was detected in BMS-5–treated glands. In addition, ectopic deposiand microtubules.
tion of FN in the interior of the epithelial bud was observed in LIMK
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and p25 siRNA–treated glands, along with
significantly reduced basal deposition at
the epithelial periphery. This FN localized
within the epithelial bud appeared to be
predominantly extracellular, both in the
mesenchyme-free rudiments and in intact
SMGs treated with LIMK and p25 siRNA
(Supplemental Figure S4, A and B).
To determine whether there is a defect in
FN assembly in the presence of LIMK inhibition, the L8 monoclonal antibody was used,
which is known to specifically bind to the
cryptic site that is unmasked when integrinbound FN undergoes conformational
changes in response to cytoskeletal stress
(Zhong et al., 1998). In control SMGs, L8 immunoreactivity was detected primarily within
the basement membranes of epithelial tissues, colocalizing with Alexa 647–FN. In
LIMK and p25 knockdown glands, such reactivity was markedly reduced, although in
BMS-5–treated glands, the L8 reduction was
less significant than in LIMK siRNA–treated
SMGs (Figure 7B). These data are consistent
with a requirement for LIMK in “inside-out”
integrin activation, enabling FN assembly
during cleft progression in developing
SMGs through regulation of both microtubule and actin stability.

FN promotes branching in an
LIMK-dependent pathway

FIGURE 6: LIMK-mediated cytoskeletal organization is necessary for focal adhesion protein
localization in the cleft region of SMGs. (A) E13 epithelial rudiments were cultured for 24 h
with negative control siRNA, BMS-5, LIMK 1, 2, or p25 siRNAs. Glands were immunostained
for FAK phosphorylated on Tyr-397 (red) and the focal adhesion protein talin (cyan) or
(B) phosphorylated FAK (Tyr-576/577) (red) and vinculin (cyan). In negative control rudiments,
pFAK Y397 and pFAK (Y576/577) with the focal adhesion protein talin and vinculin localized
to the periphery of epithelial buds (white arrow head) and along the side walls of
progressing clefts. Both pFAK Y397 and Y576/577, as well as talin and vinculin levels,
were reduced with LIMK 1/2 and p25 siRNA and BMS-5. Scale, 20 μm. (C, D) E13 SMG
treated with LIMK 1, 2 and p25 siRNA and BMS-5 were immunoblotted with antibodies
specific for pFAK Tyr-397 or Tyr-576/577. A decrease in phosphorylation at both sites was
detected after quantification relative to total FAK protein; n = 3, **p < 0.01, ***p < 0.001,
ANOVA.
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FN has been shown to increase branching
morphogenesis in a dose-dependent manner (Sakai et al., 2003). This increase in
branching was associated with an increase
in phosphorylated FAK (Y397) levels as compared with control SMG (Supplemental
Figure S3G). This increase in FAK activation
correlated with an increase in actin stability,
as seen with increased F-actin and phosphoser3-cofilin levels (Figure 8A and Supplemental Figure S3G). This is consistent with
the previously demonstrated effect of exogenously added FN stimulating increased
branching in E13 SMGs by promoting “outside-in” signaling. Of interest, when FN was
added in presence of the LIMK inhibitor
BMS-5, no significant increase in the branching pattern was observed compared with
BMS-5–treated and DMSO-treated epithelial rudiments (Figure 8B). These data thus
show that FN must be actively assembled
via a LIMK-dependent pathway to stimulate
cleft formation.

Effects of LIMK knockdown are
rescued by restoring actin and
microtubule dynamics
Bidirectional signaling between the actin
cytoskeleton and integrins (Schoenwaelder
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FIGURE 7: LIMK regulates integrin activation and FN assembly. (A) Mesenchyme-free E13 epithelial rudiments were
cultured in the presence of negative control, BMS-5, LIMK 1, LIMK 2 siRNA, or p25 siRNA, costained with a polyclonal
antibody recognizing total integrin β1 (red) and active integrin β1 (mAb 9EG7), and examined with confocal imaging.
Active integrin β1 (cyan) is detected primarily at the basal periphery of the epithelial buds (white arrowhead), and the
staining intensity is reduced in LIMK inhibitor– and siRNA–treated glands, whereas total integrin β1 is unchanged. Scale,
20 μm. (B) Mesenchyme-free E13 epithelial rudiments were cultured in the presence of Alexa 647–labeled human
plasma FN (cyan) and treated with negative control siRNA, BMS-5, LIMK 1 + 2 siRNA, or p25 siRNA and subjected to
ICC to detect assembled fibrillar FN (L8 antibody, red) by confocal imaging. BMS-5–, LIMK 1 + 2 siRNA–, and p25
siRNA–treated SMGs show a reduction in assembled FN (red) around the epithelial periphery relative to negative
control–treated SMGs. Aberrant accumulation of FN (cyan) within the epithelium is observed in LIMK 1 + 2 and p25
siRNA–treated glands. Scale, 20 μm. (C) Intact E13 SMGs were cultured in the presence of negative control siRNA,
BMS-5, LIMK 1 and 2 siRNA, p25 siRNA, or cofilin siRNA and subjected to ICC/confocal imaging to detect FN. BMS-5–,
LIMK 1 and 2 siRNA–, p25 siRNA–, and cofilin siRNA–treated SMGs show disorganized and uneven deposition of FN
(red) in the basement membrane surrounding the epithelium. Scale, 20 μm.

and Burridge, 1999; Calderwood et al., 2000) was previously investigated. It was observed that ECM binding to activated integrins is
not sufficient for matrix assembly without the dynamic remodeling
of the actin cytoskeleton (Wu et al., 1995). Because exogenous
Volume 25 August 15, 2014

addition of FN in LIMK inhibited glands could not rescue branching
morphogenesis, we hypothesized that restoration of the actin and
microtubule dynamics in the presence of LIMK down-regulation is
required to rescue cleft formation.
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FIGURE 8: FN promotes branching in a LIMK-dependent manner. (A) Treatment of E13 SMG with 0.5 mg/ml exogenous
plasma FN (cyan) for 24 h increases F-actin (green) along with an increase in cofilin phosphorylation at Ser-3 (red), as
revealed by ICC/confocal imaging. Scale, 20 μm. (B) FN-stimulated branching in E13 epithelial rudiments after 24 h is
prevented in the presence of BMS-5, as indicated by bright-field images and morphometric analysis of bud numbers in
multiple glands. Scale, 200 μm; n = 4, ***p < 0.001, ANOVA.

Because LIMK inhibition activates both cofilin and p25, we reasoned that knockdown of cofilin or p25 in the presence of LIMK
inhibition would rescue branching morphogenesis. We therefore
used cofilin siRNA to reduce cofilin levels together with the LIMK
inhibitor BMS-5 for 24 h and assayed for branching morphogenesis. As shown in Figure 9A, a significant improvement in the
branched morphology of the gland was observed upon addition
of cofilin siRNA (34% KD; Supplemental Figure S5A) in the presence of BMS-5 as compared with BMS-5–treated glands. Because
the knockdown of proteins with siRNA in organ explants does not
reach 100% efficiency, a complete rescue of branching was not
observed in glands treated with cofilin siRNA in the presence of
BMS-5. We demonstrated that LIMK knockdown affects both actin
and microtubule stability, so we attempted to rescue effects of
LIMK knockdown on cleft formation with p25 siRNA (37% KD; Supplemental Figure S5B) together with cofilin siRNA, added in the
presence of LIMK 2 siRNA (Figure 9B). With this triple KD, we detected an increased number of completed buds compared with
LIMK2 siRNA treatment, as quantified with morphometric analysis
(Figure 9B).
To confirm that the cellular and molecular responses downstream
of LIMK could be restored with knockdown of cofilin and/or p25 in
the presence of LIMK inhibition, we performed immunostaining for
the LIMK-regulated protein targets. When p25 and cofilin siRNA
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were added to cultured explants in the presence of LIMK2 siRNA,
the epithelial distribution of β-tubulin was found to be similar to the
negative control siRNA–treated glands rather than the LIMK2
siRNA–treated glands (Supplemental Figure S6A). Because we previously demonstrated that cell proliferation is inhibited by LIMK KD
through microtubule organization, we investigated the effects of cofilin and p25 KD on cell proliferation in the presence of LIMK KD.
Figure 9C shows that recovery of LIMK knockdown with simultaneous addition of cofilin and p25 siRNAs in presence of LIMK KD increased the number of EdU-positive cells compared with LIMK
siRNA treatment.
We previously demonstrated that BMS-5 and cofilin knockdown
affected the actin cytoskeleton and focal adhesion assembly in opposite ways: LIMK inhibition and KD via BMS-5 or siRNA lead to
decreased levels of actin polymerization, whereas cofilin KD increased levels of F-actin. In addition, phosphorylation of FAK adjacent to the basement membrane was decreased when LIMK was
inhibited. We reasoned that the state of the actin cytoskeleton and
localization of active FAK could be rescued by knockdown of cofilin
in the presence of LIMK inhibition. When cofilin siRNA was added
in the presence of BMS-5, F-actin dynamics were found to stabilize,
resembling the negative control–treated explants. This restored focal adhesion kinase localization at the cleft region and phosphorylation at the Tyr397 residue (Figure 10A). A similar rescue of focal
Molecular Biology of the Cell

Because LIMK-mediated signaling resulted in FN assembly and deposition to
promote cleft elongation, we investigated
whether restoration of cytoskeletal dynamics would stimulate FN fibrillogenesis in the
cleft region. We labeled the basement
membrane of epithelial rudiments under
rescue conditions with trace amounts of Alexa 647–purified human plasma FN and immunostained them with L8 monoclonal antibody. Rescue of LIMK inhibition with cofilin
siRNA (Supplemental Figure S6B) or LIMK
KD with both p25 and cofilin siRNAs led to
basally localized deposition of FN matrix in
the clefts of the rescued glands (Figure 10B).
In summary, these results confirm that maintenance of cytoskeletal dynamics through
cofilin and TPPP/p25 is essential for controlling cleft formation in mouse embryonic salivary glands. LIMK-mediated effects on cytoskeletal stability are indispensable not
only for maintaining the structural integrity
of the tissue, but also for transducing “inside-out” integrin signaling, leading to organized assembly of FN and thus facilitating
the early steps in salivary gland morphogenesis (Figure 11).

DISCUSSION
We here describe a central role for LIMK 1/2
in coordinating cytoskeletal organization in
the process of cleft formation during salivary
gland branching morphogenesis. We demonstrate that LIMK regulates the early stages
of cleft formation—cleft initiation, stabilization and progression—via promotion of Factin stability. We provide evidence that this
function of LIMK requires the actin-severing
protein cofilin. Further, we reveal a novel
role for the microtubule assembly factor p25
in regulating stabilization and progression
of late-stage progressing clefts. Our results
thus support a model in which synchronized
FIGURE 9: LIMK-mediated inhibition of branching morphogenesis is rescued by knockdown of
actin microfilament and microtubule organicofilin and p25 with up-regulation of proliferation. (A) E13 SMGs were subjected to BMS-5 ±
zation are required to exert multistep concofilin siRNA for 24 h, imaged with bright-field imaging, and subjected to morphometric
quantification of fold change in completed buds. Scale, 200 μm. LIMK inhibition of branching
trol on cleft stabilization and progression.
morphogenesis by BMS-5 is partially recovered in the presence of cofilin siRNA. The fold change Building on our previous work (Daley et al.,
in number of buds grown for 24 h shows a significant increase compared with BMS-5 treatment; 2011), we propose that cleft stabilization is
n = 3, **p < 0.01, ***p < 0.001, ANOVA. (B) E13 SMGs were subjected to LIMK 2 siRNA ± cofilin not a one-step procedure but contains muland p25 siRNA for 24 h, imaged with bright-field imaging, and subjected to morphometric
tiple stabilization steps preceding each
quantification of fold change in completed buds. Scale, 200 μm. Glands subjected to LIMK 2 KD
event of progression via newly assembled
recover morphologically in the presence of both cofilin and p25 siRNAs. The fold change in
FN. Although cofilin was previously implinumber of buds shows a significant increase in branching compared with LIMK 2 siRNA; n = 3,
cated in collective migration of border cells
***p < 0.001, ANOVA. (C) E13 SMGs were subjected to LIMK 2 siRNA ± cofilin and p25 siRNAs
during Drosophila oogenesis (Zhang et al.,
for 24 h, treated with EdU, and subjected to confocal imaging to detect EdU (red) vs. SyBr
2011) and renal branching morphogenesis
green (green). Scale, 20 μm. Fluorescence intensity quantification reveals that LIMK2-mediated
inhibition of proliferation is rescued with cofilin and p25 siRNAs by 70%; n = 3, ***p < 0.001,
(Kuure et al., 2010), this is the first report
ANOVA.
elucidating the role of LIMK and p25 in embryonic organ development.
adhesion–based cleft stability with LIMK knockdown was achieved
Our data support the model that cleft formation is highly sensiby including p25 with cofilin in presence of LIMK siRNAs, with a
tive to the assembly state of both the actin and microtubule netresulting increase in phospho-FAK (Y397) levels (Supplemental
works. Our apparently paradoxical observation that LIMK inhibition,
Figure S5C).
which causes a decrease in F-actin polymerization, and cofilin KD,
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FIGURE 10: Rescue of LIMK inhibition restores F-actin dynamics along with focal adhesion kinase activity and FN
deposition and assembly in the cleft regions of embryonic glands. (A) Mesenchyme-free E13 epithelial rudiments
treated with BMS-5, cofilin siRNA, or BMS-5 plus cofilin siRNA for 24 h were subjected to ICC/confocal imaging to
detect pFAK (Y397, red) vs. F-actin (green). The decreased F-actin with LIMK inhibition by BMS-5 and increased F-actin
with cofilin siRNA both disrupted FAK activation in the cleft region. Cofilin KD in the presence of BMS-5 stabilized actin
dynamics and restored downstream FAK activation. Scale, 20 μm. (B) Mesenchyme-free E13 epithelial rudiments treated
with control siRNA or LIMK2 ± cofilin and p25 siRNAs for 24 h were grown in the presence of Alexa 647–labeled human
plasma FN (cyan) and subjected to ICC/confocal imaging to detect assembled fibrillar FN (L8 antibody, red). The
decrease in assembled FN (L8- red) around the epithelial periphery relative to negative control–treated SMGs and
aberrant accumulation of FN (cyan) observed in the interior of the epithelium in LIMK 2 siRNA–treated glands is rescued
with simultaneous addition of cofilin and p25 siRNA. Scale, 20 μm.

which increases F-actin formation, both reduce cleft formation is
consistent with an optimal level of actin assembly being required for
cleft formation. Given our previous in silico prediction using a local
cell-based epithelial model of cleft formation that cleft progression
requires an optimal level of actin functionality (Ray et al., 2013), this
result is not surprising. Similarly, although LIMK and p25 induced
opposing effects on the stability of microtubule network, down-regulation of both proteins perturbed the developmental process. Because the inhibition of LIMK together with p25 and cofilin KD rescued branching morphogenesis, our data support the notion that
the assembly state of the cytoskeletal networks is critical for effective branching morphogenesis.
Actin filaments are required for actomyosin contraction, which
we previously reported is required for effective cleft progression
during branching morphogenesis (Daley et al., 2009). Myosin phosphatase is one factor that is required for regulation of actin contractility, which is done by regulating the activity of nonmuscle myosin
type II (Hartshorne et al., 1998). The myosin phosphatase target
subunit (MYPT1) of myosin phosphatase was recently shown to mediate a balance between the actin and microtubule cytoskeletons,
since it also regulates histone deacetylase 6 (HDAC6) both in fibroblast cells and in developing salivary glands (Joo and Yamada,
2014). This study established MYPT1 as a molecular switch that coordinates levels of actomyosin contractility and microtubule acetylation to promote branching morphogenesis by regulating surface
density of α5β1 integrin and hence FN fibrillogenesis (Joo and Yamada, 2014). Of interest, LIMK1, HDAC6, and TPPP1/p25 have
2404 | S. Ray et al.

been reported to form a trimeric complex that is responsible for increased microtubule acetylation and actin filament destabilization.
Under conditions of LIMK1 phosphorylation, the complex disintegrates and allows p25 phosphorylation, leading to microtubule destabilization and F-actin stabilization (Schofield et al., 2014). Although LIMK1 was previously shown to interact directly with p25
through the PDZ domain (Acevedo et al., 2007), it was shown in this
study that p25 binds to HDAC6, causing inhibition of its activity.
Thus LIMK may regulate microtubule stability through p25 regulation of HDAC6 to control FN fibrillogenesis.
Our observation that LIMK-dependent alterations in the cytoskeleton resulted in reduced assembly and recruitment of FA proteins is consistent with a role for LIMK in cleft stabilization by regulation of focal adhesion complexes. We previously established that
focal adhesion complex formation is critical for cleft progression in
developing salivary glands (Daley et al., 2011), and our data suggest
that LIMK participates in recruitment of focal adhesion proteins and
FAK phosphorylation. More than 100 proteins have been implicated
in focal adhesion complexes (Schaller, 2001), and the specific complexes formed are dependent on the particular cell type (Zouq et al.,
2009). We previously noted that paxillin levels were not significantly
affected by inhibition of ROCK signaling during E13 SMG development. Similarly, we noted that paxillin phosphorylation on the Src
phosphorylation site (Tyr-118; Sachdev et al., 2009) was not significantly affected by LIMK inhibition, suggesting that paxillin may not
be required for cleft formation. LIMK-mediated focal adhesion
protein recruitment within the cleft region was associated with
Molecular Biology of the Cell

FIGURE 11: Model for LIMK-mediated regulation of cleft stabilization and cleft progression in
mouse E13 salivary glands undergoing branching morphogenesis. Schematic diagram of a
proposed model for LIMK-mediated cytoskeletal changes regulating cleft formation: LIMK via
cofilin and TPPP/p25 exerts multistep control of cleft formation by affecting focal adhesion
assembly and activation and integrin activation to regulate cleft stabilization, and FN assembly
and cell proliferation to regulate cleft progression.

activation of integrin β1, as detected with the conformation-dependent antibody 9EG7. LIMK was found to participate in stimulation of
“inside-out” integrin β1 activation, which is associated with commencement of FN fibrillogenesis in the clefts (Sakai et al., 2003,
Larsen et al., 2006).
Epithelial cell polarization is an important cellular event during
branching morphogenesis that may also involve LIMK. LIMK2 activity was previously found to be negatively regulated by the apical
par protein, Par3, and Par3 binding to LIMK2 regulated actin turnover during cell polarization (Chen and Macara, 2006). Our results
demonstrate that inhibition of LIMK induced a loss of cellular organization in the epithelium, with a loss of outer cuboidal cell organization and a reduction in the area and perimeter of all epithelial
cells. Of interest, with LIMK KD we also detected accumulation of
apparently extracellular FN within the epithelial bud, reminiscent of
aberrant deposition of FN by mispolarized interior epithelial cells
induced by ROCK inhibition (Daley et al., 2012). Because our previous work showed that ROCK1-mediated Par1b localization was
required to maintain accurate basement membrane deposition
(Daley et al., 2012), further investigation of a role for LIMK in epithelial cell polarity during salivary gland branching morphogenesis is
warranted.
In this work, we focused on the epithelial functions of LIMK in
branching morphogenesis; however, LIMK may have additional
roles in the mesenchyme. In fact, we demonstrated a larger inhibition of cleft formation by LIMK KD in intact glands than in epithelial rudiments, suggesting a mesenchymal contribution to cleft
formation. In cancer cells, LIMK regulates the expression and activation of MMP 2 and MT1-MMP, affecting ECM remodeling and
metastasis (Tapia et al., 2011). Given that MT2-MMP–mediated
collagen IV deposition was found to modulate salivary gland
branching morphogenesis (Rebustini et al., 2009), LIMK may have
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an additional role in the regulation of MMP
activity during early SMG development to
control extracellular matrix and/or basement membrane remodeling. LIMK has
known functions in neuronal morphogenesis and differentiation in hippocampal neurons, neuroblastoma cells, and neuronal
cell lines (Manetti, 2012). Because parasympathetic innervation is required for effective salivary gland branching morphogenesis (Knox et al., 2010), LIMK1 may be
involved in regulation of neuronal morphogenesis during salivary gland development. Cofilin phosphorylation was previously implicated in semaphorin 3A–induced
neuronal growth cone collapse (Aizawa
et al., 2001). In mouse salivary glands,
semaphorin 3A and 3C were found to induce local epithelial signaling to regulate
cleft formation via neuropilin 1 (Npn1)
without affecting tissue proliferation
(Chung et al., 2007). It will be interesting to
examine whether LIMK is involved in semaphorin 3A–induced signaling in the SMG
and whether this pathway involves parasympathetic innervation. Further research
is required to delineate the comprehensive
contributions of LIMK to branching morphogenesis in developing salivary glands.

MATERIALS AND METHODS
Submandibular salivary gland ex vivo organ culture and
inhibitor assays
Mouse SMGs were harvested from timed-pregnant female mice
(strain CD-1; Charles River Laboratories, Troy, NY) at E13, as described previously (Bilgin et al., 2012; Daley et al., 2012; Ray et al.,
2013). SMGs were microdissected and cultured as six glands per
condition, bright-field images were acquired, and fold changes in
bud number were calculated as previously described (Daley et al.,
2012; Ray et al., 2013). SMG epithelial rudiments (five glands per
condition) were cultured in a gel with final concentration of 6 mg/ml
Matrigel (BD Biosciences, San Jose, CA) diluted in DMEM/F12 (Life
Technologies, Grand Island, NY) containing 200 ng/ml FGF7 (R&D
Systems, Minneapolis, MN). Pharmacological inhibitors were resuspended in DMSO vehicle: BMS-5 (Syn1024, 15 μM; SYNkinase, San
Diego, CA) (Ross-Macdonald et al., 2008), brefeldin A (5 μM; EMD
Millipore, Billerica, MA), and Taxol (250 nM; EMD Millipore).

siRNA knockdown of LIMK 1, LIMK 2, TPPP/p25, cdc42,
and cofilin
The following duplexed siRNAs (predesigned Ambion Silencer
Select) were obtained from Life Technologies: LIMK 1, 156129 and
s69232; LIMK 2, 156133 and s69236; TPPP/p25, s91408 and s91407;
nonmuscle cofilin, Cfl1, s63902; cdc42 siRNA, s63741; and negative
control siRNA # 1. SMGs were transfected with 500 nM siRNA using
RNAiFect (Qiagen, Valencia, CA) and cultured for 24–48 h, as we
reported previously (Daley et al., 2009)

Proliferation and apoptosis assays
For cell proliferation studies, intact E13 SMGs were cultured for 24 h
in the presence of inhibitor or vehicle control, and Click-iT Edu
(Life Technologies) was used to detect S-phase cells. SMGs were
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counterstained with SYBR Green I, and proliferation was measured
as the ratio of total pixel intensity of EdU-positive cells to that of
SYBR Green I staining. Apoptosis was assayed with cleaved caspase-3 to detect apoptotic cells and SYBR Green to label total nuclei. Ratios of EdU/SYBR green and cleaved caspase-3/SYBR green
were calculated from confocal stacks spanning the thickness of the
entire SMG and graphed in Prism (GraphPad).

Whole-mount immunocytochemistry and fluorescence
intensity measurements
Whole-mount immunocytochemistry was performed essentially as
described (Daley et al., 2012; Ray et al., 2013). SMGs were imaged
either as a stack or at the center of each explant on a Zeiss LSM 510
Meta confocal microscope at 20× (Plan Apo/0.75 numerical aperture [NA]) or 63× (Plan Apo/1.4 NA) magnification. All primary antibodies were used at a 1:100 dilution of the stock solution (unless
otherwise noted) with appropriate cyanine dye–conjugated F(ab)2
secondary antibodies (1:100; Jackson ImmunoResearch Laboratories, West Grove, PA). The following antibodies were used: LIMK 1
(Cell Signaling, Danvers, MA), LIMK 2 (clone EP969Y; Abcam,
Cambridge, MA), anti–type IV collagen (clone AB769; Millipore),
E-cadherin (clone 36, BD Biosciences, San Jose, CA), β-tubulin
(clone TUB 2.1; Sigma-Aldrich, St. Louis, MO), cofilin (phosphoSer-3; Signalway, College Park, MD), talin (clone 8d4; Sigma-Aldrich),
vinculin (clone hVIN-1; Sigma-Aldrich), integrin β1 (CD 29; clone
EP1041Y; Epitomics, Burlingame, CA), purified rat anti-mouse CD29
(clone 9EG7; BD PharMingen, San Jose, CA), cleaved caspase-3
(Asp-175; Cell Signaling), Cdc 42 (C20; Santa Cruz Biotechnology,
Dallas, TX), fibronectin rabbit polyclonal antibody R5836 (1:25), and
L8 monoclonal antibody (0.2 mg/ml). SYBR Green I (1:100,000; Life
Technologies), Alexa Fluor 488–phalloidin (1:350; Life Technologies), and fluorescent deoxyribonuclease I conjugates (1.5 μM;
Molecular Probes, Grand Island, NY) were also used for imaging.
For each image of an immunostained explant, epithelial area was
selected in each gland, and total pixel intensity was measured using
ImageJ (National Institutes of Health, Bethesda, MD) for the protein
markers (F-actin, G-actin, phospho-cofilin, and β-tubulin) and for
SYBR Green–stained nuclei. The ratio of pixel intensity of protein
markers/SYBR green was calculated from confocal stacks spanning
the thickness of the entire SMG and graphed in Prism.

FN labeling
Human plasma fibronectin (Millipore) was conjugated with Alexa
Fluor 647 Protein Labeling Kit (Life Technologies) and dialyzed overnight with Tube-o-dialyzer 4 kDa Micro (GBiosciences, St. Louis,
MO). Labeled human fibronectin was added at 0.04 μg/ml to live,
mesenchyme-free epithelial rudiments for analysis of assembled
fibronectin.

Western analysis
Protein assays (Pierce, Rockford, IL) and Western blot analysis
(Bio-Rad, Hercules, CA) were performed as previously described
(Cantara et al., 2012) with 8 μg of protein loaded/well and protein
bands quantified using ImageJ (version 1.46r) with normalization to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Levels of
each phosphorylated protein were additionally normalized to total
protein levels. Antibodies, their phosphorylated epitope (when
relevant), their dilution from stock solution, and their source are as
follows: GAPDH (1:10,000; Fitzgerald, Acton, MA), p25/TPPP (clone
EPR 3316, 1:1000; Epitomics), phospho–LIMK 1 (Thr-508; 1:500;
Abcam), phospho–LIMK 2 (T505; 1:500; Abcam), phospho-cofilin
(Ser-3; 77G2, 1:1000; Cell Signaling), cofilin (1:2000; Sigma-Aldrich),
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phospho-FAK (Tyr-576/577; 1:1000; Cell Signaling), phospho-FAK
(1:1000; Tyr-397; Cell Signaling), FAK (1:1000; Cell Signaling), phospho-paxillin (Tyr-118; 1:1000; Cell Signaling), paxillin (1:500; Cell Signaling), phospho–histone H3 (pHH3; Ser-10; 1:1000; Cell Signaling),
and histone H3 (1:1000; Cell Signaling).

Statistical analysis
For all studies, either a paired t test or one-way analysis of variance
(ANOVA), as appropriate, followed by a Bonferroni posttest from at
least three independent experiments was performed using Prism.
Error bars represent SEM.

Bright-field time-lapse microscopy and cleft depth analysis
Time-lapse microscopy was performed using a Carl Zeiss microscope essentially as previously described (Daley et al., 2009). Brightfield images were captured every 5 min for 24 h using a Zeiss Cell
Observer Z1 fitted with an environmental chamber using AxioVision
software (SE64 release 4.9.1; Carl Zeiss) at 5× (Plan Neo, NA 0.16) or
20× (Plan Neo, NA 0.5) magnification. For cleft measurements, TIFF
images were imported into MetaVue (version 7.7.5.0; Molecular Devices). Morphometric measurements were acquired using the line
tool from calibrated images of 12 clefts from six glands grown under
each growth condition.
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